We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Lung Transplantation Safe, Effective in Older Patients

By HospiMedica staff writers
Posted on 26 Mar 2008
A new study has found that lung transplantation may be safely undertaken with acceptable clinical outcomes in patients over 65 years of age.

Researchers at the University of California Los Angeles (UCLA, USA) school of medicine reviewed the records of lung transplant recipients from March 2000 to September 2006, and compared the outcomes in 50 patients aged 65 years and older with a another group of 50 patients younger than 65 years that were matched to the older cohort by means of propensity analysis. More...
The median waiting time for both groups was less than three months throughout the observation period, and decreased to 47 days after a new allocation system was implemented in May 2005. Older patients were likelier to receive single-lung transplants (76%) than were younger patients (16%), with the minority of older patients receiving double-lung transplantation for severe pulmonary hypertension or infectious lung diseases.

The researchers found that there were no intraoperative deaths and no notable differences in median duration of mechanical ventilation, intensive care unit stay, hospital stay, oxygenation parameters, or in-hospital morbidity between the groups. The occurrence of bronchiolitis obliterans syndrome (BOS) in the first post-transplantation year was about twice as high in older recipients as was in younger patients; however, the prevalence of BOS plateaued in older patients but continued to increase in younger patients. There was no statistically significant difference in the prevalence of BOS overall between patients older versus younger than 65. There was no significant difference in the in-hospital, 1-year, or 3-year survival between the groups, though there were more deaths during the 1-month to 1-year interval in the older group because of infections, probably due to immunosenescence of the older patients. The study was published in the February 2008 issue of The Journal of Thoracic and Cardiovascular Surgery.

"Lung transplantation can be performed safely and with comparable short-term and medium-term survival in selected patients older than 65 years,” concluded lead author Raja Mahidhara, M.D., and colleagues of the division of cardiothoracic surgery. "However, multidisciplinary consensus is needed to determine the ethical standards in offering lung transplantation to the elderly given the critically short supply of donor organs.”

Current consensus guidelines recommend an upper age limit of 65 years for single-lung transplantation and 60 years for double-lung transplantation.


Related Links:
University of California Los Angeles

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.